Literature DB >> 16731947

Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus.

Veronika von Messling1, Nicholas Svitek, Roberto Cattaneo.   

Abstract

Experimental infections of ferrets with canine distemper virus (CDV) recapitulate many hallmarks of measles: rash, high fever, viremia, depression of delayed-type hypersensitivity responses, lowered leukocyte counts, and reduced lymphocyte proliferation activity. To understand how a morbillivirus invades the host and causes immunosuppression, we generated CDV either unable to recognize one of the receptors or incapable of expressing either one or both of the candidate interferon antagonist proteins V and C. Variants of these viruses expressing green fluorescent protein were also generated. Striking similarities between CDV infection of ferrets and human immunodeficiency virus host invasion were documented: first, massive early replication in the gut-associated lymphatic tissue, including intestinal Peyer's patches, followed by extensive infection of lymphatic organs, including thymus and circulating lymphocytes. Moreover, T cells were selectively depleted. Thus, CDV takes advantage of mucosal surfaces for host invasion and lymphocytes for swift dissemination. A CDV unable to recognize the signaling lymphocytic activation molecule (SLAM [CD150]) that is expressed in lymphocytes and other immune cells did not spread. A V-defective CDV multiplied with reduced efficiency in lymphocytes and did not inhibit the interferon and cytokine responses. Protein C affected the severity of rash and digestive symptoms elicited by V-defective CDV, but it was dispensable for the invasion of the lymphatic organs. These findings prove formally that SLAM recognition is necessary for morbillivirus virulence. They also reveal how two viral proteins affect pathogenesis: V sustains the swift lymphocyte-based invasion of mucosal tissue and lymphatic organs, whereas C sustains subsequent infection phases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731947      PMCID: PMC1472607          DOI: 10.1128/JVI.00357-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Wild-type measles virus infection in human CD46/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection.

Authors:  Masashi Shingai; Naokazu Inoue; Tsuyoshi Okuno; Masaru Okabe; Takashi Akazawa; Yasuhide Miyamoto; Minoru Ayata; Kenya Honda; Mitsue Kurita-Taniguchi; Misako Matsumoto; Hisashi Ogura; Tadatsugu Taniguchi; Tsukasa Seya
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

Review 2.  Immune regulation by SLAM family receptors and SAP-related adaptors.

Authors:  André Veillette
Journal:  Nat Rev Immunol       Date:  2006-01       Impact factor: 53.106

3.  AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding.

Authors:  Takemasa Sakaguchi; Atsushi Kato; Fumihiro Sugahara; Yukie Shimazu; Makoto Inoue; Katsuhiro Kiyotani; Yoshiyuki Nagai; Tetsuya Yoshida
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection.

Authors:  Joseph J Mattapallil; Daniel C Douek; Brenna Hill; Yoshiaki Nishimura; Malcolm Martin; Mario Roederer
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease.

Authors:  M B Oldstone; H Lewicki; D Thomas; A Tishon; S Dales; J Patterson; M Manchester; D Homann; D Naniche; A Holz
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

6.  Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain.

Authors:  Christina M Ulane; Alex Kentsis; Cristian D Cruz; Jean-Patrick Parisien; Kristi L Schneider; Curt M Horvath
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.

Authors:  Taro Kawai; Ken Takahashi; Shintaro Sato; Cevayir Coban; Himanshu Kumar; Hiroki Kato; Ken J Ishii; Osamu Takeuchi; Shizuo Akira
Journal:  Nat Immunol       Date:  2005-08-28       Impact factor: 25.606

8.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.

Authors:  Rashu B Seth; Lijun Sun; Chee-Kwee Ea; Zhijian J Chen
Journal:  Cell       Date:  2005-09-09       Impact factor: 41.582

9.  Measles virus replication in lymphatic cells and organs of CD150 (SLAM) transgenic mice.

Authors:  G Grant Welstead; Caterina Iorio; Ryan Draker; Jane Bayani; Jeremy Squire; Sompong Vongpunsawad; Roberto Cattaneo; Christopher D Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-31       Impact factor: 11.205

10.  Stringent requirement for the C protein of wild-type measles virus for growth both in vitro and in macaques.

Authors:  Kaoru Takeuchi; Makoto Takeda; Naoko Miyajima; Yasushi Ami; Noriyo Nagata; Yuriko Suzaki; Jamila Shahnewaz; Shin-Ichi Kadota; Kyosuke Nagata
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

View more
  69 in total

1.  Canine distemper virus epithelial cell infection is required for clinical disease but not for immunosuppression.

Authors:  Bevan Sawatsky; Xiao-Xiang Wong; Sarah Hinkelmann; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

2.  Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus.

Authors:  D Silin; O Lyubomska; M Ludlow; W P Duprex; B K Rima
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

3.  Disease duration determines canine distemper virus neurovirulence.

Authors:  François Bonami; Penny A Rudd; Veronika von Messling
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

4.  Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry.

Authors:  Bevan Sawatsky; Roberto Cattaneo; Veronika von Messling
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

Review 5.  Paramyxovirus disruption of interferon signal transduction: STATus report.

Authors:  Aparna Ramachandran; Curt M Horvath
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

6.  Measles virus breaks through epithelial cell barriers to achieve transmission.

Authors:  Makoto Takeda
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

7.  Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed.

Authors:  Vincent H J Leonard; Patrick L Sinn; Gregory Hodge; Tanner Miest; Patricia Devaux; Numan Oezguen; Werner Braun; Paul B McCray; Michael B McChesney; Roberto Cattaneo
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

8.  Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys.

Authors:  Patricia Devaux; Gregory Hodge; Michael B McChesney; Roberto Cattaneo
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

9.  Canine distemper virus persistence in demyelinating encephalitis by swift intracellular cell-to-cell spread in astrocytes is controlled by the viral attachment protein.

Authors:  Gaby Wyss-Fluehmann; Andreas Zurbriggen; Marc Vandevelde; Philippe Plattet
Journal:  Acta Neuropathol       Date:  2010-02-02       Impact factor: 17.088

10.  Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates.

Authors:  Anne Schaap-Nutt; Christopher D'Angelo; Margaret A Scull; Emerito Amaro-Carambot; Machiko Nishio; Raymond J Pickles; Peter L Collins; Brian R Murphy; Alexander C Schmidt
Journal:  Virology       Date:  2009-12-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.